Search Results - "Jayson, Avital"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Novel method for quantifying cells on carriers and its demonstration during SARS‐2 vaccine development by Rosen, Osnat, Jayson, Avital, Natan, Niva, Monash, Arik, Girshengorn, Meni, Goldvaser, Michael, Levin, Lilach, Epstein, Eyal

    Published in Biotechnology and bioengineering (01-10-2021)
    “…The most effective way to prevent and control infectious disease outbreak is through vaccines. The increasing use of vaccines has elevated the need to…”
    Get full text
    Journal Article
  2. 2

    Optimization of VSV‐ΔG‐spike production process with the Ambr15 system for a SARS‐COV‐2 vaccine by Rosen, Osnat, Jayson, Avital, Goldvaser, Michael, Dor, Eyal, Monash, Arik, Levin, Lilach, Cherry, Lilach, Lupu, Edith, Natan, Niva, Girshengorn, Meni, Epstein, Eyal

    Published in Biotechnology and bioengineering (01-07-2022)
    “…To face the coronavirus disease 2019 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus, our institute has developed the…”
    Get full text
    Journal Article
  3. 3

    Application of Ambr15 system for simulation of entire SARS‐CoV‐2 vaccine production process involving macrocarriers by Jayson, Avital, Goldvaser, Michael, Dor, Eyal, Monash, Arik, Levin, Lilach, Cherry, Lilach, Lupu, Edith, Natan, Niva, Girshengorn, Meni, Epstein, Eyal, Rosen, Osnat

    Published in Biotechnology progress (01-09-2022)
    “…The Ambr15 system is an automated, high‐throughput bioreactor platform which comprises 24 individually controlled, single‐use stirred‐tank reactors. This…”
    Get full text
    Journal Article
  4. 4

    Poly(vinyl alcohol)‐methacrylate with CRGD peptide: A photocurable biocompatible hydrogel by Goldvaser, Michael, Epstein, Eyal, Rosen, Osnat, Jayson, Avital, Natan, Niva, Ben‐Shalom, Tal, Saphier, Sigal, Katalan, Shahaf, Shoseyov, Oded

    “…Polyvinyl alcohol (PVA)‐based hydrogels are promising biomaterials for tissue engineering printing applications. However, one of their main disadvantages is…”
    Get full text
    Journal Article
  5. 5

    A Simple Method for in situ Quantification of Cells on Carriers by Rosen, Osnat, Jayson, Avital, Natan, Niva, Epstein, Eyal

    Published in Bio-protocol (05-12-2021)
    “…The technology of cell carriers was developed as a response to the need for high cell density to enable higher production levels in cell-based production…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    In-Line Monitoring of Downstream Purification Processes for VSV Based SARS-CoV-2 Vaccine Using a Novel Technique by Makovitzki, Arik, Jayson, Avital, Oren, Ziv, Lerer, Elad, Kafri, Yaron, Dor, Eyal, Cherry, Lilach, Tzadok, Hanan, Levin, Lilach, Hazan, Ophir, Simon, Irit, Tal, Arnon, Girshengorn, Meni, Rosen, Osnat

    Published in Biotech (Basel) (03-11-2021)
    “…The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases the need for a rapid development of efficient vaccines…”
    Get full text
    Journal Article
  9. 9

    SARS-CoV-2 spike antigen quantification by targeted mass spectrometry of a virus-based vaccine by Rosen, Osnat, Jayson, Avital, Dor, Eyal, Epstein, Eyal, Makovitzki, Arik, Cherry, Lilach, Lupu, Edith, Monash, Arik, Borni, Sarah, Baruchi, Tzadok, Laskar, Orly, Shmaya, Shlomo, Rosenfeld, Ronit, Levy, Yinon, Schuster, Ofir, Feldberg, Liron

    Published in Journal of virological methods (01-05-2022)
    “…•The spike glycoprotein of SARS-CoV-2 mediates virus binding to host cells’ receptors and is a key target for vaccines development.•The spike induces a…”
    Get full text
    Journal Article